DJIA 16,365.71 103.15 0.63%
NASDAQ 4,062.47 28.31 0.70%
S&P 500 1,851.39 8.41 0.46%
market minute promo



142.57 2.73 (1.95%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $142.03 1.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $141.36
Previous Close $139.84
Daily Range $139.44 - $142.70
52-Week Range $110.53 - $174.66
Market Cap $57.9B
P/E Ratio 41.50
Dividend (Yield) $0.00 (0.0%)
Volume 646,198
Average Daily Volume 4,515,726
Current FY EPS $6.34





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Can Celgene Deliver in 2014?

Celgene (NASDAQ: CELG) had a strong 2013, but 2014 is not quite going to plan. Can it turn things around?

Gilead: This Baby Has Been Thrown Away With The Bathwater

Anacor Pharma Remains Over-Valued on Development of Inferior Drugs

Stock Market News for April 14, 2014 - Market News

Celgene Growth Unappreciated In Recent Sell-Off

3 Stocks Reiterated As A Buy: CAT, CELG, CMCSA

Stock Market News for April 11, 2014 - Market News

3 Drugs Stocks Driving The Industry Higher

Today's Market: Playing The Biotech Bloodbath

Three Biotech Companies That Look To Be Good Buys After A Pullback

Tech stock rout continues in Asia

Asia tech stocks fall into the red

See More CELG News...

CELG's Top Competitors

CELG $142.57 (1.95%)
Current stock: CELG
AMGN $115.18 (0.16%)
Current stock: AMGN
GILD $69.29 (1.64%)
Current stock: GILD
$0.00 (0.00%)
Current stock: